Pancreatic cancer
Treatment studies at every stage, help with symptoms, and research into finding the disease sooner.
Read about Pancreatic cancerTreatment for bleeding disorders has changed a great deal, and studies now compare longer-acting medicines, injections under the skin and gene therapy.
In a bleeding disorder the blood does not clot as it should, because a clotting protein is missing, low or not working. Hemophilia A is a shortage of factor VIII and hemophilia B of factor IX. Von Willebrand disease is the most common bleeding disorder and affects women and men alike, often showing up as heavy periods, nosebleeds or bleeding after dental work.
Studies test replacement factors that last longer, medicines that are not factors at all and are injected under the skin, and gene therapy given once, followed by years of check-ups. Others look at joint health, at bleeding disorders in women, and at people who have developed inhibitors, the antibodies that stop factor working.

Most studies in this area fall into one of these groups. A listing usually says which one in its first lines.
Compare a new regular treatment with what a person uses now, counting bleeds over time.
Test medicines given less often and without a vein, for adults and sometimes children.
A one-time infusion, then long follow-up with frequent blood tests at first.
Research for people with inhibitors, and on keeping knees, ankles and elbows healthy.
What studies in this area often involve, and what a study team is likely to ask you for.
Write them down before you call. A good team expects them, and the answers help you decide.
Treatment studies at every stage, help with symptoms, and research into finding the disease sooner.
Read about Pancreatic cancerScarring of the lung tissue, the cough and breathlessness it brings, and the medicines that try to slow it.
Read about Pulmonary fibrosisAmyotrophic lateral sclerosis: medicines that aim to slow it, gene-targeted research, and help with breathing and speech.
Read about ALSSign up with this area chosen for you. We write now and then about research in it, by email, and by text if you check the box.